Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 386

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 386
---
2022: £485k; 2021: £619k)
and laboratory equipment of net book value £Nil (2022: £2k; 2021: £44k).

On
1 February 2023 laboratory equipment previously disclosed within right of use assets was transferred to laboratory equipment when the
final payment on the finance lease was made. On 1 January 2022 software previously disclosed within computer equipment was transferred
to intangible assets.

| F-48 |

| 10 | Leases |

| Schedule of market rental rates       |     |            |   |     |            |   |     |            |   |
| Lease Liabilities                     |     | 2023 £’000 |   |     | 2022 £’000 |   |     | 2021 £’000 |   |
| At 1 January                          |     |        624 |   |     |        766 |   |     |         76 |   |
| Additions                             |     |          – |   |     |          – |   |     |        720 |   |
| Transfer                              |     |          – |   |     |          – |   |     |         77 |   |
| Effect of modification to lease terms |     |          – |   |     |          – |   |     |        (24 | ) |
| Interest expenses                     |     |         28 |   |     |         36 |   |     |         29 |   |
| Lease payments                        |     |       (188 | ) |     |       (178 | ) |     |       (112 | ) |
| At 31 December                        |     |        464 |   |     |        624 |   |     |        766 |   |

The right of use assets is disclosed in note 9.

In
April 2021 the Group signed an agreement to lease new premises in Cardiff, Wales, to house its corporate offices and laboratories. The
agreement to lease allowed the Group to carry out the Cat A works and fit out prior to completion of the lease and its occupation in August
2021. The lease agreed was for a 5 year period with no break clause. The lease was recognised as a right of use asset in 2021. The recognition
in 2021 of the right of use asset and corresponding lease liability were a non cash investing and financing transaction.

In
May 2021 the Group